Furthermore, FAK is significantly up-regulated in ovarian cancer (p = 1.71e-5), more than any other tumor site53 and FAK overexpression has been linked to poor prognosis with an over two-fold decrease in median survival52. This evidence concerns the gene PTK2 and ovarian carcinoma.